Bausch Health Companies (BHC) Total Debt (2009 - 2026)
Bausch Health Companies (BHC) reported Total Debt of $21.7 billion for Q1 2026, down 0.64% on a YoY basis from $21.8 billion in Q1 2025, and up 2.9% sequentially from $21.0 billion in Q4 2025.
Bausch Health Companies (BHC) Total Debt (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Total Debt data on file, last reported at $21.7 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Debt fell 0.64% year-over-year to $21.7 billion; the trailing twelve-month figure through Mar 2026 stood at $21.7 billion (down 0.64% YoY), and the FY2025 full-year result was $21.0 billion, down 2.66% from the prior year.
- Total Debt improved to $21.7 billion in Q1 2026, from $21.0 billion in the prior quarter.
- In the past five years, Total Debt ranged from a high of $23.2 billion in Q1 2022 to a low of $20.6 billion in Q2 2023.
- A 5-year average of $21.8 billion and a median of $21.7 billion in 2024 frame the typical range for Total Debt.
- Peak annual rise in Total Debt reached 8.25% in 2023, while the deepest fall reached 8.93% in 2023.
- Tracing BHC's Total Debt over 5 years: stood at $21.2 billion in 2022, then increased by 5.61% to $22.4 billion in 2023, then fell by 3.45% to $21.6 billion in 2024, then declined by 2.66% to $21.0 billion in 2025, then climbed by 2.9% to $21.7 billion in 2026.
- Business Quant data shows BHC's Total Debt at $21.7 billion in Q1 2026, $21.0 billion in Q4 2025, and $21.0 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 21.65 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.65 Bn |
| Dec 31, 2025 | 21.04 Bn |
| Sep 30, 2025 | 21.04 Bn |
| Jun 30, 2025 | 22.62 Bn |
| Mar 31, 2025 | 21.79 Bn |
| Dec 31, 2024 | 21.62 Bn |
| Sep 30, 2024 | 21.96 Bn |
| Jun 30, 2024 | 21.66 Bn |
| Mar 31, 2024 | 22.07 Bn |
| Dec 31, 2023 | 22.39 Bn |
| Sep 30, 2023 | 22.97 Bn |
| Jun 30, 2023 | 20.55 Bn |
| Mar 31, 2023 | 21.10 Bn |
| Dec 31, 2022 | 21.20 Bn |
| Sep 30, 2022 | 21.22 Bn |
| Jun 30, 2022 | 21.96 Bn |
| Mar 31, 2022 | 23.17 Bn |
| Dec 31, 2021 | 22.65 Bn |
| Sep 30, 2021 | 22.36 Bn |
| Jun 30, 2021 | 23.44 Bn |